Skip to main content
Clinical Trials/CTRI/2023/05/052846
CTRI/2023/05/052846CompletedUnknown

Clinical Evaluation of Efficacy and Safety of Ambhring Age Embrace Revitalizer Hair Oil in improving hair health including hair volume, hair softness, and hair strength in healthy adult volunteers

Transformative Learning Solutions Pvt Ltd0 sites33 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Unknown
Status
Completed
Sponsor
Enrollment
33

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • 1. Male and female subjects in general good health.
  • 2. Subjects in the age group of 18-55 years (both ages inclusive).
  • 3. Subjects complaining of hair fall and damage.
  • 4. Subjects willing to give a written informed consent and willing to abide by and
  • comply with the study protocol.
  • 5. Subjects falling under Grade 3 - Grade 6 of hair loss severity grade evaluated
  • as per MSCR photo numerical 10-point scale (Linear scale for assessment
  • purpose-In Use Scale).

Exclusion Criteria

  • 1.Subjects who have undergone hair growth treatment within 3 months before
  • screening into the study.
  • 2. Subjects having any active scalp disease which may interfere in the study –
  • dermatologist’s judgement.
  • 3. Subjects who have undergone chemotherapy for cancer in the 6 months prior
  • to start of the study or have a plan to do treatments during study.
  • 4. Subjects who have history of alcoholism, smoking, crash dieting and/ or
  • psychiatric disorder including trichotillomania.
  • Subjects who have had hair transplant, who have taken pharmaceutical product
  • which cause hirsutism (ex. phenytoin) and finasteride for androgenic alopecia,
  • under medical treatment for hair problems.
  • 6. Subjects who consume vitamins and food supplements that may interfere with
  • 7. Subjects who wear wig or hair extensions
  • 8. Subjects on oral medications, undergoing any chemical hair salon treatment straightening / perming / colour/ henna which will compromise the study.
  • 9. Subjects with chronic illness which may influence the study.
  • 10. Subjects who are pregnant or lactating or nursing as established with medical
  • 11. Menopausal female subjects as determined by medical history.
  • 12. Subjects participating in other similar cosmetic or therapeutic trial within last
  • three months.
  • 13. Subjects with any history of underlying uncontrolled medical illness including
  • diabetes mellitus, hypertension, HIV, hepatitis, severe anemia, serious disorder
  • of heart and respiratory apparatus or any other serious medical illness.

Investigators

Sponsor
Transformative Learning Solutions Pvt Ltd

Similar Trials